196 related articles for article (PubMed ID: 33402361)
1. Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy.
Ma L; Gonzalez-Junca A; Zheng Y; Ouyang H; Illa-Bochaca I; Horst KC; Krings G; Wang Y; Fernandez-Garcia I; Chou W; Barcellos-Hoff MH
Clin Cancer Res; 2021 Mar; 27(6):1778-1791. PubMed ID: 33402361
[TBL] [Abstract][Full Text] [Related]
2. Aggressive Mammary Cancers Lacking Lymphocytic Infiltration Arise in Irradiated Mice and Can Be Prevented by Dietary Intervention.
Omene C; Ma L; Moore J; Ouyang H; Illa-Bochaca I; Chou W; Patel MS; Sebastiano C; Demaria S; Mao JH; Karagoz K; Gatza ML; Barcellos-Hoff MH
Cancer Immunol Res; 2020 Feb; 8(2):217-229. PubMed ID: 31831632
[TBL] [Abstract][Full Text] [Related]
3. Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes.
Nguyen DH; Fredlund E; Zhao W; Perou CM; Balmain A; Mao JH; Barcellos-Hoff MH
Clin Cancer Res; 2013 Mar; 19(6):1353-62. PubMed ID: 23339125
[TBL] [Abstract][Full Text] [Related]
4. Densely ionizing radiation acts via the microenvironment to promote aggressive Trp53-null mammary carcinomas.
Illa-Bochaca I; Ouyang H; Tang J; Sebastiano C; Mao JH; Costes SV; Demaria S; Barcellos-Hoff MH
Cancer Res; 2014 Dec; 74(23):7137-48. PubMed ID: 25304265
[TBL] [Abstract][Full Text] [Related]
5. Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type.
Nguyen DH; Oketch-Rabah HA; Illa-Bochaca I; Geyer FC; Reis-Filho JS; Mao JH; Ravani SA; Zavadil J; Borowsky AD; Jerry DJ; Dunphy KA; Seo JH; Haslam S; Medina D; Barcellos-Hoff MH
Cancer Cell; 2011 May; 19(5):640-51. PubMed ID: 21575864
[TBL] [Abstract][Full Text] [Related]
6. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
[TBL] [Abstract][Full Text] [Related]
7. Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment.
Quintana E; Schulze CJ; Myers DR; Choy TJ; Mordec K; Wildes D; Shifrin NT; Belwafa A; Koltun ES; Gill AL; Singh M; Kelsey S; Goldsmith MA; Nichols R; Smith JAM
Cancer Res; 2020 Jul; 80(13):2889-2902. PubMed ID: 32350067
[TBL] [Abstract][Full Text] [Related]
8. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
9. RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer.
Tentler JJ; Lang J; Capasso A; Kim DJ; Benaim E; Lee YB; Eisen A; Bagby SM; Hartman SJ; Yacob BW; Gittleman B; Pitts TM; Pelanda R; Eckhardt SG; Diamond JR
BMC Cancer; 2020 Nov; 20(1):1063. PubMed ID: 33148223
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog Signaling Regulates Metabolism and Polarization of Mammary Tumor-Associated Macrophages.
Hinshaw DC; Hanna A; Lama-Sherpa T; Metge B; Kammerud SC; Benavides GA; Kumar A; Alsheikh HA; Mota M; Chen D; Ballinger SW; Rathmell JC; Ponnazhagan S; Darley-Usmar V; Samant RS; Shevde LA
Cancer Res; 2021 Nov; 81(21):5425-5437. PubMed ID: 34289986
[TBL] [Abstract][Full Text] [Related]
11. TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo.
Bouquet F; Pal A; Pilones KA; Demaria S; Hann B; Akhurst RJ; Babb JS; Lonning SM; DeWyngaert JK; Formenti SC; Barcellos-Hoff MH
Clin Cancer Res; 2011 Nov; 17(21):6754-65. PubMed ID: 22028490
[TBL] [Abstract][Full Text] [Related]
12. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
[TBL] [Abstract][Full Text] [Related]
13. Loss of Cdh1 and Trp53 in the uterus induces chronic inflammation with modification of tumor microenvironment.
Stodden GR; Lindberg ME; King ML; Paquet M; MacLean JA; Mann JL; DeMayo FJ; Lydon JP; Hayashi K
Oncogene; 2015 May; 34(19):2471-82. PubMed ID: 24998851
[TBL] [Abstract][Full Text] [Related]
14. SHIP represses lung inflammation and inhibits mammary tumor metastasis in BALB/c mice.
Hamilton MJ; Halvorsen EC; LePard NE; Bosiljcic M; Ho VW; Lam V; Banáth J; Bennewith KL; Krystal G
Oncotarget; 2016 Jan; 7(4):3677-91. PubMed ID: 26683227
[TBL] [Abstract][Full Text] [Related]
15. Pubertal and adult windows of susceptibility to a high animal fat diet in Trp53-null mammary tumorigenesis.
Zhu Y; Aupperlee MD; Zhao Y; Tan YS; Kirk EL; Sun X; Troester MA; Schwartz RC; Haslam SZ
Oncotarget; 2016 Dec; 7(50):83409-83423. PubMed ID: 27825136
[TBL] [Abstract][Full Text] [Related]
16. Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer.
De Martino M; Daviaud C; Diamond JM; Kraynak J; Alard A; Formenti SC; Miller LD; Demaria S; Vanpouille-Box C
Cancer Immunol Res; 2021 Jan; 9(1):89-102. PubMed ID: 33093219
[TBL] [Abstract][Full Text] [Related]
17. Ionizing radiation downregulates estradiol synthesis via endoplasmic reticulum stress and inhibits the proliferation of estrogen receptor-positive breast cancer cells.
Yang P; Feng X; Li J; Zhang T; Sheng C; Zhang L; Hua J; Wei W; Ding N; He J; Zhang Y; Wang J; Zhou H
Cell Death Dis; 2021 Oct; 12(11):1029. PubMed ID: 34716300
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
[TBL] [Abstract][Full Text] [Related]
19. NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences.
Nizam E; Köksoy S; Erin N
Cancer Immunol Immunother; 2020 Aug; 69(8):1639-1650. PubMed ID: 32322911
[TBL] [Abstract][Full Text] [Related]
20. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.
Jia XH; Feng GW; Wang ZL; Du Y; Shen C; Hui H; Peng D; Li ZJ; Kong DL; Tian J
Oncotarget; 2016 Apr; 7(15):20934-44. PubMed ID: 26988913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
